NIH-funded research R01 grant

Using CRISPR technology to improve sensory and motor skills in a mouse model of autism

Official title: CRISPRa-based rescue of sensorimotor deficits in the Scn2a+/- mouse model of autism spectrum disorder

Funded at University of California, San Francisco · NIH-11059916 · Data updated 2026-11-12

This study is exploring a new way to boost a gene linked to autism in mice to see if it can help improve their sensory and motor skills, which could lead to better treatments for people with autism.

More Autism research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startApril 1, 2024
Project endJanuary 31, 2029
Funding year2025
Award (this year)$571,865
NIH project number5R01MH136475-02
Project IDNIH-11059916 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research would be individuals with autism spectrum disorder linked to SCN2A mutations.

Less likely to help

Patients without SCN2A mutations or those with other forms of autism may not benefit from this specific research.

What this research studies

This research investigates the use of CRISPR activation technology to enhance the function of a gene associated with autism, specifically in a mouse model that mimics certain aspects of the disorder. The study focuses on restoring the expression of the SCN2A gene, which is crucial for proper neuronal function, to alleviate deficits in sensory processing and motor skills. By applying this innovative genetic approach, the researchers aim to improve both cellular and behavioral outcomes in these mice, potentially leading to new therapeutic strategies for autism. The research will involve detailed assessments of the effects of CRISPRa on brain function and behavior in the mouse model.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve sensory and motor functions in individuals with autism spectrum disorder.

How similar studies have gone: Other research has shown promise in using CRISPR technology for genetic interventions, suggesting potential success for this approach in autism treatment.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Bender, Kevin J — University of California, San Francisco
  • Study coordinator: Bender, Kevin J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.